Arne Astrup
Arne Astrup
Head, professor, Department of Nutrition, Exercise and sports, University of Copenhagen
Verified email at nexs.ku.dk
TitleCited byYear
Obesity: preventing and managing the global epidemic
World Health Organization
World Health Organization, 2000
19185*2000
Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies
A Flint, A Raben, JE Blundell, A Astrup
International journal of obesity 24 (1), 38, 2000
16032000
Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans.
A Flint, A Raben, A Astrup, JJ Holst
The Journal of clinical investigation 101 (3), 515-520, 1998
13461998
Effect of sibutramine on weight maintenance after weight loss: a randomised trial
WPT James, A Astrup, N Finer, J Hilsted, P Kopelman, S R÷ssner, ...
The Lancet 356 (9248), 2119-2125, 2000
10572000
Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials
R Christensen, PK Kristensen, EM Bartels, H Bliddal, A Astrup
The Lancet 370 (9600), 1706-1713, 2007
9582007
Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study
A Astrup, S R÷ssner, L Van Gaal, A Rissanen, L Niskanen, M Al Hakim, ...
The Lancet 374 (9701), 1606-1616, 2009
9112009
Randomized trial on protein vs carbohydrate in ad libitum fat reduced diet for the treatment of obesity
AR Skov, S Toubro, B R°nn, L Holm, A Astrup
International journal of obesity 23 (5), 528, 1999
8871999
Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans
JM Bruun, AS Lihn, C Verdich, SB Pedersen, S Toubro, A Astrup, ...
American journal of physiology-Endocrinology and metabolism 285 (3), E527-E533, 2003
8852003
Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide
A Astrup, R Carraro, N Finer, A Harper, M Kunesova, MEJ Lean, ...
International journal of obesity 36 (6), 843, 2012
818*2012
Sucrose compared with artificial sweeteners: different effects on ad libitum food intake and body weight after 10 wk of supplementation in overweight subjects
A Raben, TH Vasilaras, AC M°ller, A Astrup
The American journal of clinical nutrition 76 (4), 721-729, 2002
7822002
Diets with high or low protein content and glycemic index for weight-loss maintenance
TM Larsen, SM Dalskov, M van Baak, SA Jebb, A Papadaki, AFH Pfeiffer, ...
New England Journal of Medicine 363 (22), 2102-2113, 2010
7672010
A Meta-Analysis of the Effect of Glucagon-Like Peptide-1 (7–36) Amide on Ad Libitum Energy Intake in Humans
C Verdich, A Flint, JP Gutzwiller, E Naslund, C Beglinger, PM Hellstrom, ...
The Journal of Clinical Endocrinology & Metabolism 86 (9), 4382-4389, 2001
7132001
A randomized, controlled trial of 3.0 mg of liraglutide in weight management
X Pi-Sunyer, A Astrup, K Fujioka, F Greenway, A Halpern, M Krempf, ...
New England Journal of Medicine 373 (1), 11-22, 2015
7102015
Effect of weight reduction in obese patients diagnosed with knee osteoarthritis: a systematic review and meta-analysis
R Christensen, EM Bartels, A Astrup, H Bliddal
Annals of the rheumatic diseases 66 (4), 433-439, 2007
6262007
The role of low-fat diets in body weight control: a meta-analysis of ad libitum dietary intervention studies
A Astrup, GK Grunwald, EL Melanson, WHM Saris, JO Hill
International journal of obesity 24 (12), 1545, 2000
5912000
The role of reducing intakes of saturated fat in the prevention of cardiovascular disease: where does the evidence stand in 2010?
A Astrup, J Dyerberg, P Elwood, K Hermansen, FB Hu, MU Jakobsen, ...
The American journal of clinical nutrition 93 (4), 684-688, 2011
5662011
Protein, weight management, and satiety
D Paddon-Jones, E Westman, RD Mattes, RR Wolfe, A Astrup, ...
The American journal of clinical nutrition 87 (5), 1558S-1561S, 2008
5532008
Dietary carbohydrate restriction as the first approach in diabetes management: critical review and evidence base
RD Feinman, WK Pogozelski, A Astrup, RK Bernstein, EJ Fine, ...
Nutrition 31 (1), 1-13, 2015
4962015
Redefining type 2 diabetes:‘diabesity’or ‘obesity dependent diabetes mellitus’?
A Astrup, N Finer
obesity reviews 1 (2), 57-59, 2000
4702000
Myths, presumptions, and facts about obesity
K Casazza, KR Fontaine, A Astrup, LL Birch, AW Brown, ...
New England Journal of Medicine 368 (5), 446-454, 2013
4602013
The system can't perform the operation now. Try again later.
Articles 1–20